Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications.

Tarimoboere Agbalalah Doofan Bur Ezinne Janefrances Nwonu Adekunle Babajide Rowaiye

Published in: Anemia (2024)

Further exploration and clinical trials are needed to harness the full potential of these gut bacteria for individuals affected by this challenging condition.

Keyphrases

sickle cell disease
clinical trial
human health

neuropathic pain
risk assessment

spinal cord
open label

phase iii
postoperative pain